Envestnet Asset Management Inc Maxcyte, Inc. Transaction History
Envestnet Asset Management Inc
- $299 Billion
- Q1 2025
A detailed history of Envestnet Asset Management Inc transactions in Maxcyte, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 12,346 shares of MXCT stock, worth $35,926. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,346
Previous 15,561
20.66%
Holding current value
$35,926
Previous $64,000
48.44%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding MXCT
# of Institutions
124Shares Held
70.6MCall Options Held
8.7KPut Options Held
6K-
Cadian Capital Management, LP New York, NY9.34MShares$27.2 Million2.26% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$23.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.43MShares$15.8 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$14.7 Million18.06% of portfolio
-
Morgan Stanley New York, NY4.41MShares$12.8 Million0.0% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $296M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...